Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), today announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems along with BR.io, a cloud-based instrument connectivity, ...

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support researchers in ...

The CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems represent the next generation of the company’s CFX Real-Time PCR Systems that are used in research and genomic testing as well as in pathogen ...

Bio-Rad Laboratories, Inc. a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the availability of Biogazelle’s qbasePLUS, qPCR data ...

The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing. Bio-Rad Laboratories, Inc.

Bio-Rad’s CFX Opus Deepwell Real-Time PCR Detection System is designed to support researchers in developing nucleic acid detection assays. Bio-Rad Laboratories’s new CFX Opus Deepwell Real-Time ...

BioRad Laboratories CFX Duet System is designed to help researchers develop singleplex and duplex quantitative polymerase chain reaction assays. Bio-Rad Laboratories announced the launch of the CFX ...

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX ™ Opus 96 Dx System and the CFX ™ Opus 384 Dx System, ...